REFRACTORY GMG

Clinical trials for REFRACTORY GMG explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY GMG trials appear

Sign up with your email to follow new studies for REFRACTORY GMG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Breakthrough drug tested for patients who failed all other treatments

Disease control Completed

This study tested whether the drug eculizumab could help control severe myasthenia gravis in Chinese patients whose disease didn't respond to other treatments. Fifteen participants with significant muscle weakness received the drug for 26 weeks while researchers measured improvem…

Matched conditions: REFRACTORY GMG

Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

REFRACTORY GMG

Get alerted when new REFRACTORY GMG trials appear

Breakthrough drug tested for patients who failed all other treatments